ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

ClinicalTrials.gov ID: NCT01592773

Public ClinicalTrials.gov record NCT01592773. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Study identification

NCT ID
NCT01592773
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Forest Laboratories
Industry
Enrollment
747 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Years to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2012
Primary completion
Dec 31, 2013
Completion
Feb 28, 2014
Last update posted
Feb 15, 2015

2012 – 2014

United States locations

U.S. sites
68
U.S. states
31
U.S. cities
65
Facility City State ZIP Site status
Forest Investigative Site 068 Dothan Alabama 36303
Forest Investigative Site 005 Phoenix Arizona 85006
Forest Investigative Site 055 Tucson Arizona 85718
Forest Investigative Site 077 Little Rock Arkansas 72202-3591
Forest Investigative Site 054 Glendale California 91206
Forest Investigative Site 109 Imperial California 92251
Forest Investigative Site 066 Irvine California 92612
Forest Investigative Site 096 Los Angeles California 90024
Forest Investigative Site 021 San Francisco California 94143-0984
Forest Investigative Site 026 Santa Ana California 92701
Forest Investigative Site 002 Stanford California 94305-5719
Forest Investigative Site 078 Boulder Colorado 80304
Forest Investigative Site 073 Centennial Colorado 80112
Forest Investigative Site 052 Washington D.C. District of Columbia 20010-2970
Forest Investigative Site 075 Bradenton Florida 32751
Forest Investigative Site 080 Gainesville Florida 32607
Forest Investigative Site 117 Jacksonville Florida 32216
Forest Investigative Site 065 Maitland Florida 32751
Forest Investigative Site 118 Miami Florida 33155
Forest Investigative Site 085 Oakland Park Florida 33334
Forest Investigative Site 115 Orange City Florida 32763
Forest Investigative Site 125 Orlando Florida 32803
Forest Investigative Site 062 Orlando Florida 32806
Forest Investigative Site 067 Tampa Florida 33613
Forest Investigative Site 101 Wellington Florida 33414
Forest Investigative Site 102 Libertyville Illinois 60048
Forest Investigative Site 023 Naperville Illinois 60563
Forest Investigative Site 082 Evansville Indiana 47713
Forest Investigative Site 123 Fort Wayne Indiana 46805
Forest Investigative Site 056 Indianapolis Indiana 46260
Forest Investigative Site 061 Louisville Kentucky 40202
Forest Investigative Site 095 Lake Charles Louisiana 70605
Forest Investigative Site 091 New Orleans Louisiana 70112
Forest Investigative Site 086 Rockville Maryland 20852
Forest Investigative Site 059 Newton Massachusetts 02459
Forest Investigative Site 108 Springfield Massachusetts 01199
Forest Investigative Site 116 Lincoln Nebraska 68516
Forest Investigative Site 097 Lincoln Nebraska 68526
Forest Investigative Site 130 Henderson Nevada 89052
Forest Investigative Site 104 Las Vegas Nevada 89128
Forest Investigative Site 136 Neptune City New Jersey 07753
Forest Investigative Site 127 Toms River New Jersey 08755
Forest Investigative Site 081 Albuquerque New Mexico 87108-5129
Forest Investigative Site 107 Albuquerque New Mexico 87109
Forest Investigative Site 098 The Bronx New York 10467
Forest Investigative Site 072 Chapel Hill North Carolina 27514
Forest Investigative Site 069 Avon Lake Ohio 44012
Forest Investigative Site 001 Columbus Ohio 43210
Forest Investigative Site 019 Oklahoma City Oklahoma 73116
Forest Investigative Site 092 Tulsa Oklahoma 74104
Forest Investigative Site 053 Gresham Oregon 97030
Forest Investigative Site 132 Johnstown Pennsylvania 15904
Forest Investigative Site 131 McMurray Pennsylvania 15317
Forest Investigative Site 100 Media Pennsylvania 19063
Forest Investigative Site 105 Charleston South Carolina 29407
Forest Investigative Site 090 Memphis Tennessee 38119
Forest Investigative Site 057 Nashville Tennessee 37232
Forest Investigative Site 051 Houston Texas 77090
Forest Investigative Site 070 The Woodlands Texas 77381
Forest Investigative Site 028 Clinton Utah 84015
Forest Investigative Site 141 Ogden Utah 84405
Forest Investigative Site 029 Salt Lake City Utah 84106
Forest Investigative Site 064 Charlottesville Virginia 22903
Forest Investigative Site 113 Norfolk Virginia 23507
Forest Investigative Site 124 Roanoke Virginia 24014
Forest Investigative Site 071 Bothell Washington 98011
Forest Investigative Site 119 Charleston West Virginia 25304
Forest Investigative Site 063 Middleton Wisconsin 53562

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01592773, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 15, 2015 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01592773 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →